On 12/4/23 a beta bionics clinical diabetes specialist (cds) stated a patient reported to her via email of a severe hypoglycemic event.The exact date of the event is unknown, but it occurred around (b)(6) 2023.The patient reported: "at night my fiancé hears the dexcom alarm and wakes me and i haven't checked insulin on board.But at one point i was "very low" for over 2% of past two days.Several times during day i passed out my sugar was so low at night he really struggled to wake me, which is not common, so it is definitely going very low." the night the patient's blood glucose (bg) went low, her fiancé gave the patient a glucagon shot because the patient lost consciousness.The patient regained consciousness after the glucagon was injected and was okay after.The patient did not have a diabetic seizure.No emt/firefighters were needed.The cds reported the patient has increased her bg target to higher.The cds has reviewed the following topics with the patient since her training: importance of meal announcements, not announcing fake carbs, not taking injections and not overtreating low bg with carbs to avoid hypoglycemia and ilet algorithm maladaptation.
|
No product was returned for evaluation.The ilet logs were reviewed by beta bionics failure investigation department.Based on the engineering logs, the ilet is behaving as intended.The ilet logged an expired continuous glucose monitor (cgm) sensor and referenced its last valid blood glucose (bg) reading of 140mg/dl.Due to this reading, the ilet continued to request basal deliveries of approximately 0.06 units of insulin.Basal deliveries were continued until cgm signal was reestablished.After reconnection to the cgm transmitter, the ilet was found to adjust/pause basal deliveries based on bg values it was receiving.No product performance issues were identified.If the product is received at a later date, the complaint will be reopened and investigated accordingly.No anomalies were observed.The device history record (dhr) review was completed, and this device passed all manufacturing release criteria for distribution.There were no issues identified that would have impacted this event.
|